Advanced therapy for eternal vulvovaginal candidiasis recurrences
Candidiasis is the most common fungal infection predominantly affecting the mucous membrane. The fungus Candida causes these lesions. There are strains resistant to modern antimycotic drugs among Candida spp. Due to the increase in candidiasis prevalence and the widespread use of antifungal agents,...
Main Author: | I. A. Kulikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-10-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5805 |
Similar Items
-
Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
by: Diletta Rosati, et al.
Published: (2020-01-01) -
The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
by: Sh M Pogosyan, et al.
Published: (2017-06-01) -
Sertaconazole in the treatment of vulvovaginal candidiasis
by: Z. N. Efendieva
Published: (2019-10-01) -
Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital
by: Latha Ragunathan, et al.
Published: (2014-05-01) -
Natamycin in the treatment of chronic recurrent vulvovaginal candidiasis associated with intestinal candidiasis
by: I. O. Malova, et al.
Published: (2018-09-01)